NEW YORK – Johnson & Johnson (JNJ) has sued Amgen (AMGN), accusing the world's largest biotechnology company of hampering sales of J&J's anemia drug, Procrit (search), by using anti-competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback